Difference between revisions of "Team:Vilnius-Lithuania/Attributions"
| Line 58: | Line 58: | ||
<div class="column half_size" > | <div class="column half_size" > | ||
<div class="inlBlock100"> | <div class="inlBlock100"> | ||
| − | <img class="leftImg40" src="https://static.igem.org/mediawiki/2016/3/36/T--Vilnius-Lithuania--marketing.png"> | + | <img class="leftImg40" src="https://static.igem.org/mediawiki/2016/thumb/3/36/T--Vilnius-Lithuania--marketing.png/320px-T--Vilnius-Lithuania--marketing.png"> |
<h2 class="Raleway">Marketing</h2> | <h2 class="Raleway">Marketing</h2> | ||
</hr> | </hr> | ||
| Line 64: | Line 64: | ||
</div> | </div> | ||
<div class="inlBlock100"> | <div class="inlBlock100"> | ||
| − | <img class="leftImg40" src="https://static.igem.org/mediawiki/2016/1/1f/T--Vilnius-Lithuania--rnd.png"> | + | <img class="leftImg40" src="https://static.igem.org/mediawiki/2016/thumb/1/1f/T--Vilnius-Lithuania--rnd.png/320px-T--Vilnius-Lithuania--rnd.png"> |
<h2 class="Raleway">Laboratory team</h2> | <h2 class="Raleway">Laboratory team</h2> | ||
</hr> | </hr> | ||
| Line 91: | Line 91: | ||
</div class="inlBlock100"> | </div class="inlBlock100"> | ||
<div> | <div> | ||
| − | <img class="leftImg40x2" src="https://static.igem.org/mediawiki/2016/f/f0/T--Vilnius-Lithuania--pr.png"> | + | <img class="leftImg40x2" src="https://static.igem.org/mediawiki/2016/thumb/f/f0/T--Vilnius-Lithuania--pr.png/265px-T--Vilnius-Lithuania--pr.png"> |
<h2 class="Raleway">Public Relations</h2> | <h2 class="Raleway">Public Relations</h2> | ||
</hr> | </hr> | ||
Revision as of 20:26, 18 October 2016
People
Marketing
The marketing department was responsible for creating our commercial offer, communicating with potential sponsors and handling our finances.
Laboratory team
The people who did the most of the labwork by testing our phenylalanine ammonia-lyase and Polyphe protein approaches.
Modelling
In order to find the most stable mutants having multiple phenylalanine residues, we have developed a script based on R programming language. This script uses FoldX protein modeling program as a tool for protein mutagenesis and stability calculation. The script and its manual can be accessed at GitHub.
Interlab Group
Our team participated in one of the largest interlaboratory studies in synthetic biology. We contributed by helping establishing a baseline for replicability of fluorescence measurements and identified likely key sources of error.
Human Practices
Our human practices team organized a number of public discussions on current issues in life sciences such as GMOs, CRISPR/Cas9 system or ethical issues concerning the treatment of genetic diseases. We also met with specialists working with the treatment of phenylketonuria (PKU) in Lithuania to discussed the need for additional treatment options. Finally, we presented our project to the Lithuanian PKU patients’ association.
Public Relations
Our public relations department took care of our social media accounts such as Facebook and Twitter. We wrote a number of articles to most of Lithuanian news websites and an article to Bored Panda.
Acknowledgements
Laboratory
Rolandas Meškys, PhD Kotryna Kvederavičiūtė, PhD student Giedrius Gasiūnas, PhD Mantvyda Marija Grušytė, MSc Edita Sužiedelienė, PhD Gintautas Tamulaitis, PhD Giedrė Tamulaitienė Miglė Kazlauskienė, PhD student Paulius Toliušis, PhD student Irmantas Mogila, BSc
Ideas
Rolandas Meškys, PhD Audrius Gegeckas, PhD Loreta Cimbalistienė, PhD Mindaugas Zaremba, PhD Karolis Misiūnas, PhD student Giedrius Vilkaitis, PhD Ceslovas Venslovas, PhD Daumantas Matulis, PhD
Human Practices
Rytis Kalinauskas, BSc Edgaras Kuodys, BSc Veronika Dedonytė, PhD Lilija Kalėdienė, PhD Eugenijus Butkus, PhD Simonas Liutika, BSc student Dalia Matuliauskienė
Coding & Design
Konstantin Junovič, BSc Algis Kriščiūnas, BSc Miglė Mikutėnaitė, BSc Giedrė Mikutėnaitė, BSc student Gintvilė Bergerytė, BSc student
Autobahn Group, Inc.
Association
Rūta Jauniškienė Aurelija Olendraitė
Sponsors
